Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma
Authors:
- Wade ChristopherWCWade Christopher
- Sean NassoiySNSean Nassoiy
- Rebecca MarcusRMRebecca Marcus
- Jennifer KellerJKJennifer Keller
- Shu-Ching ChangSCShu-Ching Chang
- Trevan FischerTFTrevan Fischer
- Anton BilchikABAnton Bilchik
- Melanie GoldfarbMGMelanie Goldfarb
Open Access
- 28 September 2022
- journal article
- research article
- Published by Elsevier in Surgery in Practice and Science
- Vol. 11
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Using the National Cancer Database for Outcomes ResearchJAMA Oncology, 2017
- Staging of pancreatic cancer based on the number of positive lymph nodesBritish Journal of Surgery, 2017
- Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched AnalysisJournal of Clinical Oncology, 2017
- Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort studyActa Oncologica, 2015
- Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and SurvivalJournal of Gastrointestinal Surgery, 2013
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic CancerJAMA, 2013
- Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant TherapyJournal of the American College of Surgeons, 2012
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesPLOS Medicine, 2010
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999